Zulfa Omer

449 total citations
14 papers, 237 citations indexed

About

Zulfa Omer is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Zulfa Omer has authored 14 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 3 papers in Molecular Biology and 3 papers in Hematology. Recurrent topics in Zulfa Omer's work include Chronic Lymphocytic Leukemia Research (5 papers), Galectins and Cancer Biology (3 papers) and Health and Well-being Studies (2 papers). Zulfa Omer is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Galectins and Cancer Biology (3 papers) and Health and Well-being Studies (2 papers). Zulfa Omer collaborates with scholars based in United States, United Kingdom and Sudan. Zulfa Omer's co-authors include Sigal Shachar, Zvi Livneh, Emma Searle, John C. Byrd, Alvaro J. Alencar, Salma M. Abdalla, Francesco Forconi, Graham P. Collins, Sarah G. Injac and Dima El‐Sharkawi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cell Cycle.

In The Last Decade

Zulfa Omer

10 papers receiving 229 citations

Peers

Zulfa Omer

GHP

ONCOL

Annique Claringbould Netherlands

Anthony Colombo United States

Patricia Sexton United States

Emily Cousins United Kingdom

Sonali Verma India

Jin You United States

Michael Kersten Germany

Michelle M. J. Mens Netherlands

Ayesha Sheikh Pakistan

Azhar Khandekar United States

Annique Claringbould Netherlands

Zulfa Omer

249 ×1.7

38 ×0.7

52 ×1.4

26 ×0.8

GHP

18 ×0.6

ONCOL

Citations per year, relative to Zulfa Omer Zulfa Omer (= 1×) peers Annique Claringbould

Countries citing papers authored by Zulfa Omer

Since Specialization

Citations

This map shows the geographic impact of Zulfa Omer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zulfa Omer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zulfa Omer more than expected).

Fields of papers citing papers by Zulfa Omer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zulfa Omer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zulfa Omer. The network helps show where Zulfa Omer may publish in the future.

Co-authorship network of co-authors of Zulfa Omer

This figure shows the co-authorship network connecting the top 25 collaborators of Zulfa Omer. A scholar is included among the top collaborators of Zulfa Omer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zulfa Omer. Zulfa Omer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

El‐Sharkawi, Dima, David Lewis, Zulfa Omer, et al.. (2025). IBCL-675: Bexobrutideg (NX-5948), a Novel Bruton’s Tyrosine Kinase (BTK) Degrader, Shows High Clinical Activity and Tolerable Safety in an Ongoing Phase 1a/b Study in Patients With Waldenström Macroglobulinemia (WM). Clinical Lymphoma Myeloma & Leukemia. 25. S825–S825.

Shaikh, Hira, et al.. (2025). Outcomes and Prognostic Assessment of Post-Transplant Lymphoproliferative Disorder: 20-Year Experience. SHILAP Revista de lepidopterología. 3(1). 5–5. 1 indexed citations

El‐Sharkawi, Dima, David Lewis, Zulfa Omer, et al.. (2025). POSTER: IBCL-675 Bexobrutideg (NX-5948), a Novel Bruton’s Tyrosine Kinase (BTK) Degrader, Shows High Clinical Activity and Tolerable Safety in an Ongoing Phase 1a/b Study in Patients With Waldenström Macroglobulinemia (WM). Clinical Lymphoma Myeloma & Leukemia. 25. S275–S275.

Omer, Zulfa, Jennifer A. Woyach, Seema A. Bhat, et al.. (2024). Clinical Characteristics and Outcome in a Cohort of CLL Patients with BTK T474 Gatekeeper Mutation. Blood. 144(Supplement 1). 1875–1875.

Shah, Nirav N., Zulfa Omer, Graham P. Collins, et al.. (2024). Efficacy and Safety of the Bruton's Tyrosine Kinase (BTK) Degrader NX-5948 in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Updated Results from an Ongoing Phase 1a/b Study. Blood. 144(Supplement 1). 884–884. 13 indexed citations

Woyach, Jennifer A., Danielle M. Brander, Boyu Hu, et al.. (2024). LP-168 (Rocbrutinib), a Novel Covalent and Non-Covalent Next-Generation Inhibitor of Bruton's Tyrosine Kinase: Updates on the Phase 1 Trial and Initial Results of the CLL Gatekeeper Mutation Cohort. Blood. 144(Supplement 1). 4622–4622. 4 indexed citations

Shaikh, Hira, Zulfa Omer, Roman Jandarov, & Tahir Latif. (2022). HL-172 FDG-PET/CT as a Tool for Early Detection of Bleomycin-Induced Pulmonary Toxicity. Clinical Lymphoma Myeloma & Leukemia. 22. S345–S345.

Omer, Zulfa, et al.. (2022). Reversal of life-threatening bleeding with protamine sulfate in a patient with plasma cell leukemia. Blood Coagulation & Fibrinolysis. 33(7). 425–428. 1 indexed citations

Abdalla, Salma M., et al.. (2018). Operationalization of patients’ rights in Sudan: Quantifying nurses’ knowledge. Nursing Ethics. 26(7-8). 2239–2246. 4 indexed citations

10.

Mudawi, Hatim, et al.. (2016). Histopathological features of coeliac disease in a sample of Sudanese patients.. PubMed. 38(3). 267–272. 2 indexed citations

11.

Omer, Zulfa, et al.. (2016). Depression, Anxiety, and Stress in Sudanese Medical Students: A Cross Sectional Study on Role of Quality of Life and Social Support. American Journal of Educational Research. 4(13). 937–942. 32 indexed citations

12.

Omer, Zulfa, et al.. (2016). Validity and reliability of Arabic MOS social support survey. SpringerPlus. 5(1). 1306–1306. 26 indexed citations

13.

Livneh, Zvi, Zulfa Omer, & Sigal Shachar. (2010). Multiple two-polymerase mechanisms in mammalian translesion DNA synthesis. Cell Cycle. 9(4). 729–735. 138 indexed citations

14.

Omer, Zulfa. (1970). On the D-N Model of Scientific Explanation. Philosophy of Science. 37(3). 417–433. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact